Randomized Amifostine For SCCHN

NCT00095927 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Chemotherapeutic Agent Toxicity
Head and Neck Cancer
Mucositis
Radiation Toxicity
Xerostomia

Interventions

DRUG: Amifostine
DRUG: Carboplatin
DRUG: Paclitaxel
RADIATION: radiation

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]